Renal function, digoxin therapy, and heart failure outcomes: Evidence from the digoxin intervention group trial

Journal of the American Society of Nephrology

Volumn 15, Issue 8, 2004, Pages 2195-2203

  Shlipak, Michael G ^a,b   Smith, Grace L ^c   Rathore, Saif S ^c   Massie, Barry M ^a,b   Krumholz, Harlan M ^c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRIC ACID DERIVATIVE; VASODILATOR AGENT;

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

EID: 3543070534     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000135121.81744.75     Document Type: Article

References (42)

1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 139: 137-147, 2003
2. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38: 955-962, 2001
3. Kearney MT, Fox KA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, Eckberg DL, Zaman AG, Williams S, Neilson JM, Nolan J: Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 40: 1801-1808, 2002
4. McClellan WM, Flanders WD, Langston RD, Jurkovitz C, Presley R: Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 13: 1928-1936, 2002
5. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35: 681-689, 2000
6. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102: 203-210, 2000
7. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS: The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40: 1106-1113, 2002
8. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. J Card Fail 5: 357-382, 1999
9. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol 83: 1A-38A, 1999
10. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38: 2101-2113, 2001
11. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92, 2003
12. Doherty JE, Flanigan WJ, Dalrymple GV: Tritiated digoxin. XVII. Excretion and turnover times in normal donors before and after nephrectomy and in the paired recipient of the kidney after transplantation. Am J Cardiol 29: 470-474, 1972
13. Doherty JE: Clinical use of digitalis glycosides. An update. Cardiology 72: 225-254, 1985
14. Okada RD, Hager WD, Graves PE, Mayersohn M, Perrier DG, Marcus FI: Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Circulation 58: 1196-1203, 1978
15. Rambausek M, Ritz E: Digitalis in chronic renal insufficiency. Blood Purif 3: 4-14, 1985
16. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM: Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289: 871-878, 2003
17. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336: 525-533, 1997
18. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: A large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Control Clin Trials 17: 77-97, 1996
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
20. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39: S1-246, 2002
21. Muntwyler J, Abetel G, Gruner C, Follath F: One-year mortality among unselected outpatients with heart failure. Eur Heart J 23: 1861-1866, 2002
22. Bettencourt P, Ferreira A, Dias P, Pimenta J, Prices F, Martins L, Cerqueira-Gomes M: Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail 6: 306-313, 2000
23. Shlipak MG, Browner WS, Noguchi H, Massie B, Frances CD, McClellan M: Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. Am J Med 110: 425-433, 2001
24. Philbin EF: Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol 21: 103-108, 1998
25. Shlipak MG: Pharmacotherapy for heart failure in patients with renal insufficiency. Ann Intern Med 138: 917-924, 2003
26. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J: Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162: 1401-1408, 2002
27. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 39: 1780-1786, 2002
28. Mozaffarian D, Nye R, Levy WC: Anemia predicts mortality in severe heart failure. The prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 41: 1933-1939, 2003
29. Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M: High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36: 1587-1593, 2000
30. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD: Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102: 3060-3067, 2000
31. Brewster UC, Setaro JF, Perazella MA: The renin-angiotensin-aldosterone system: Cardiorenal effects and implications for renal and cardiovascular disease States. Am J Med Sci 326: 15-24, 2003
32. Kramer BK, Schweda F, Riegger GA: Diuretic treatment and diuretic resistance in heart failure. Am J Med 106: 90-96, 1999
33. Cody RJ, Kubo SH, Pickworth KK: Diuretic treatment for the sodium retention of congestive heart failure. Arch Intern Med 154: 1905-1914, 1994
34. Brater DC: Diuretic therapy. N Engl J Med 339: 387-395, 1998
35. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, Robbins JA, Gardin JM: Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. JAMA 279: 585-592, 1998
36. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Mild renal insufficiency as a predictor of cardiovascular outcomes and all-cause mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
37. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134: 629-636, 2001
38. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD: Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38: 705-711, 2001
39. Green CP, Porter CB, Bresnahan DR, Spertus JA: Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure. J Am Coll Cardiol 35: 1245-1255, 2000
40. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB: Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 129: 286-293, 1998
41. Cody RJ, Ljungman S, Covit AB, Kubo SH, Sealey JE, Pondolfino K, Clark M, James G, Laragh JH: Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int 34: 361-367, 1988
42. Rathore SS, Wang Y, Krumholz HM: Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347: 1403-1411, 2002